Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib
Andreas Hochhaus(Heidelberg University), Michele Baccarani(University of Bologna), Michael W. Deininger(Oregon Health & Science University), Jane F. Apperley(Hammersmith Hospital), Jeffrey H. Lipton(Princess Margaret Cancer Centre), Stuart L. Goldberg(Hackensack University Medical Center), Sélim Corm(Université de Lille), Neil P. Shah(University of California, San Francisco), Francisco Cervantes(Hospital Clínic de Barcelona), Richard T. Silver(NewYork–Presbyterian Hospital), Dietger Niederwieser(Leipzig University), Richard M. Stone(Dana-Farber Cancer Institute), Hervé Dombret(Hôpital Saint-Louis), Richard A. Larson(University of Chicago), Lydia Roy(Centre Hospitalier Universitaire de Poitiers), Timothy P. Hughes(South Australia Pathology), Martin C. Müller(Heidelberg University), Rana Ezzeddine(Bristol-Myers Squibb (United States)), Athena Countouriotis(Bristol-Myers Squibb (United States)), H. Kantarjian(The University of Texas MD Anderson Cancer Center)
Cited by 354
Abstract
Related Papers
No related papers found
Powered by citation graph analysis